The price you pay for Cequa may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...
Cequa (cyclosporine) and Restasis (cyclosporine) are prescription drugs used to treat chronic (long-term) dry eye. Both drugs come as an eye drop you use twice per day. This article explains the main ...
Please provide your email address to receive an email when new articles are posted on . And just like that, we have two. Two non-preserved cyclosporine A drops for ...
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters:SUN.BO, Bloomberg:SUNP IN, NSE:SUNPHARMA, BSE:524715, “Sun Pharma” and includes its subsidiaries and/or ...
Please provide your email address to receive an email when new articles are posted on . Whoa! That sure happened fast. Did you see that coming? The whole dry eye marketplace turned upside down in — ...
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries ...
Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA ® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...
Sun is trading at 16x FY21 PE, a 20% discount to peers. Sun announced the launch of its dry eye treatment drug Cequa. We expect it to have $70m peak sales in two years. While Restasis genericization ...
Sun Pharma, India's largest drug maker, on October 14 announced the launch of the much awaited specialty drug Cequa to treat dry eye disease in US. The launch, which was originally planned in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback